← All companies

GKOS

Glaukos Corporation

GKOS NYSE Surgical & Medical Instruments & Apparatus EDGAR ↗

$170.87

+2.35 +1.39%

Key statistics

from XBRL data in SEC filings

Market cap

$10.1B

Revenue (TTM)

$613M

Net income (TTM)

-$188M

EPS (TTM)

$-3.27

P/E ratio

—

Dividend yield

—

Free cash flow

-$22.5M

Cash

$114M

Total assets

$921M

Gross margin

60.7%

52-week range

$73.16 – $184.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Aug 3, 2026 10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 29, 2026 8-K Shareholder vote results Jun 3, 2026 8-K Regulation FD disclosure May 4, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 29, 2026 8-K Regulation FD disclosure Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 17, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 8-K Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-09-30 Oct 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 29, 2025 8-K Regulation FD disclosure Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2025 8-K Shareholder vote results Jun 3, 2025 8-K Regulation FD disclosure May 14, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2025 8-K Regulation FD disclosure Mar 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 20, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Regulation FD disclosure Dec 9, 2024 8-K Entered a material agreement Dec 3, 2024 8-K Regulation FD disclosure Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2024 8-K Other events Oct 11, 2024 8-K Regulation FD disclosure Aug 9, 2024 8-K/A Results of operations (earnings release) Aug 2, 2024 10-Q Quarter ended 2024-06-30 Aug 2, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 31, 2024 8-K Unregistered sale of equity; Other events Jun 28, 2024 8-K Unregistered sale of equity; Other events Jun 14, 2024 8-K Director or officer change; Shareholder vote results Jun 5, 2024 8-K Regulation FD disclosure May 20, 2024 10-Q Quarter ended 2024-03-31 May 3, 2024